The global Animal Drug Compounding Market size was valued at USD 1.7 billion in 2025 and is projected to grow from USD 1.8 billion in 2026 to USD 3.3 billion by 2033, registering a CAGR of 8.5% from 2026 to 2033. North America accounted for the largest revenue share of 37.2% in 2025, driven by advanced veterinary healthcare infrastructure, high pet ownership rates, and increasing...

"According to the latest report published by Data Bridge Market Research, the Bevacizumab Market Data Bridge Market Research analyses that the market, which was USD 6,679.14 million in 2022, would rocket up to USD 12,967.08 million by 2030 and is expected to undergo a CAGR of 9.20% during the forecast period.  Bevacizumab Market report has been framed by chewing over an...

The global Dietary Supplements Market was valued at USD 209.5 billion in 2025 and is projected to grow from USD 228.2 billion in 2026 to USD 431.7 billion by 2033, expanding at a CAGR of 9.5% from 2026 to 2033. The market is witnessing robust growth due to increasing health awareness, changing consumer lifestyles, and a growing preference for preventive healthcare over reactive...

The global Microfluidics Market was valued at USD 41.9 billion in 2025 and is projected to grow from USD 46.9 billion in 2026 to USD 105.1 billion by 2033, registering a CAGR of 12.2% from 2026 to 2033. North America accounted for the largest revenue share of 42.8% in 2025, driven by the rapid adoption of microfluidic technologies across diagnostics, biomedical research, drug...

"According to the latest report published by Data Bridge Market Research, the Nucleic Acid-Based Drugs Market Data Bridge Market Research analyzes that the global nucleic acid-based drugs market, which was USD 32.05 million in 2022, is likely to reach USD 135.97 million by 2030 and is expected to undergo a CAGR of 19.80% during the forecast period.  The persuasive Nucleic...

The global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

The global Synthetic Biology Market was valued at USD 18.9 billion in 2025 and is projected to grow from USD 22.1 billion in 2026 to USD 69.2 billion by 2033, registering a robust CAGR of 17.7% from 2026 to 2033. The market is witnessing significant expansion as advances in genetic engineering, genome editing, and biological system design continue to unlock new opportunities across...

    Molecular Biological Reagents market was valued at US$ 10,120 million in 2024 and is projected to reach US$ 18,230 million by 2031, expanding at a robust compound annual growth rate (CAGR) of 9.0% during the forecast period. This sustained growth highlights the critical role molecular biological reagents play across healthcare, life sciences research, and biotechnology...

    Precision Medicine market continues to demonstrate strong momentum within the healthcare and life sciences landscape. Valued at USD 130,400 million in 2024, the market is projected to reach USD 256,430 million by 2031, expanding at a compound annual growth rate (CAGR) of 10.4% during the forecast period. This robust expansion highlights the growing shift toward individualized...